Kyowa Medex Releases Diagnostic Reagent for Type 3 Familial Hyperlipemia.Tokyo, Japan, Feb 23, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Kyowa Medex, a Kyowa Hakko subsidiary, announced on February 22 that it has launched Metaboread/Metabolead RemL-C, a reagent for diagnosing type 3 familial hyperlipemia hyperlipemia /hy·per·li·pe·mia/ (-li-pe´me-ah) hyperlipidemia. carbohydrate-induced hyperlipemia . Requiring no preprocessing A preliminary processing of data in order to prepare it for the primary processing or for further analysis. The term can be applied to any first or preparatory processing stage when there are several steps required to prepare data for the user. , the new agent can be used with general-purpose analyzers and can assess remnant lipoprotein lipoprotein (lĭp'əprō`tēn), any organic compound that is composed of both protein and the various fatty substances classed as lipids, including fatty acids and steroids such as cholesterol. cholesterol levels in about 10 minutes. Remnant lipoprotein cholesterol is a kind of risk factor of atherosclerosis. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion